The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Astellas Pharma Europe B.V.'s (ALPMF) Xospata (
FibroGen (FGEN) and collaboration partner Astellas Pharma (ALPMF) announce approval of Evrenzo (roxadustat) in Japan for the treatment of chronic kidney di
The Centers for Medicare & Medicaid Services (CMS) has issued its final update on the therapies facing expiration of pass-through status in 2018.Normal Medicare reimbursement...
Seattle Genetics, Inc. (NASDAQ:SGEN) announced that it will discontinue the phase III study, CASCADE o vadastuximab talirine (SGN-CD33A) in frontline older acute myeloid leukemia...
Cytomegalovirus (CMV) is one of the most common viruses in the world. It's ubiquitous in all populations, and it's a herpesvirus, meaning it causes a lifelong, persistent infection...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Buy||Strong Buy||Buy||Buy|
|Technical Indicators||Sell||Strong Buy||Strong Buy||Strong Buy||Strong Sell|
|Summary||Neutral||Strong Buy||Strong Buy||Strong Buy||Neutral|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Inside Up||1M||4||Jun 19|
|Tri-Star Bullish||15||4||Oct 11, 2019 01:00PM|
|Three Outside Down||1M||6||Apr 19|
|Engulfing Bearish||1M||7||Mar 19|
|Doji Star Bearish||15||11||Oct 11, 2019 09:45AM|
Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.Read More
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.